Form 8-K - Current report:
SEC Accession No. 0001104659-21-011824
Filing Date
2021-02-04
Accepted
2021-02-03 21:29:46
Documents
16
Period of Report
2021-02-03
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 2.06: Material Impairments
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm215161d1_8k.htm   iXBRL 8-K 38071
2 EXHIBIT 99.1 tm215161d1_ex99-1.htm EX-99.1 9000
3 EXHIBIT 99.2 tm215161d1_ex99-2.htm EX-99.2 532360
4 EXHIBIT 99.3 tm215161d1_ex99-3.htm EX-99.3 232518
8 GRAPHIC tm215161d1_ex99-1img001.jpg GRAPHIC 3023
  Complete submission text file 0001104659-21-011824.txt   1084318

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA asrt-20210203.xsd EX-101.SCH 3193
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE asrt-20210203_lab.xml EX-101.LAB 34592
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asrt-20210203_pre.xml EX-101.PRE 22715
9 EXTRACTED XBRL INSTANCE DOCUMENT tm215161d1_8k_htm.xml XML 3612
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

EIN.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39294 | Film No.: 21588545
SIC: 2834 Pharmaceutical Preparations